ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Invasive Fungal Disease (IFD) Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-7V17426
Home | Market Reports | Health| Health Conditions
Global Invasive Fungal Disease IFD Drugs Market Research Report 2024
BUY CHAPTERS

Global Invasive Fungal Disease (IFD) Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7V17426
Report
October 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Merck
Gilead Sciences
Xellia
Lupin Ltd
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical

Invasive Fungal Disease (IFD) Drugs Market Size

The global Invasive Fungal Disease (IFD) Drugs market is projected to grow from US$ 2704 million in 2024 to US$ 3592 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

Invasive Fungal Disease (IFD) Drugs Market

Invasive Fungal Disease (IFD) Drugs Market

Invasive Fungal Disease (IFD) refers to an infectious disease in which fungi invade the human body, grow and multiply in tissues, organs or blood, and cause inflammatory reactions and tissue damage. The main pathogenic bacteria are Aspergillus and Candida.The mainstream treatment methods for IFD are drug treatment and prevention. The mainstream drugs are triazole drugs, including posaconazole, itraconazole, fluconazole and voriconazole.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Invasive Fungal Disease (IFD) Drugs leading manufacturers including Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Pfizer leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Invasive Fungal Disease (IFD) Drugs market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Invasive Fungal Disease (IFD) Drugs Market Report

Report Metric Details
Report Name Invasive Fungal Disease (IFD) Drugs Market
Accounted market size in 2024 US$ 2704 million
Forecasted market size in 2031 US$ 3592 million
CAGR 4.2%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Oral Medicine
  • Injectable Medicine
Segment by Application
  • Hospital
  • Drugstore
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Invasive Fungal Disease (IFD) Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Invasive Fungal Disease (IFD) Drugs Market growing?

Ans: The Invasive Fungal Disease (IFD) Drugs Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Invasive Fungal Disease (IFD) Drugs Market size in 2031?

Ans: The Invasive Fungal Disease (IFD) Drugs Market size in 2031 will be US$ 3592 million.

Who are the main players in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The main players in the Invasive Fungal Disease (IFD) Drugs Market are Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical

What are the Application segmentation covered in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The Applications covered in the Invasive Fungal Disease (IFD) Drugs Market report are Hospital, Drugstore, Clinic, Others

What are the Type segmentation covered in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The Types covered in the Invasive Fungal Disease (IFD) Drugs Market report are Oral Medicine, Injectable Medicine

1 Study Coverage
1.1 Introduction to Invasive Fungal Disease (IFD) Drugs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oral Medicine
1.2.3 Injectable Medicine
1.3 Market Segmentation by Application
1.3.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Invasive Fungal Disease (IFD) Drugs Revenue Estimates and Forecasts 2020-2031
2.2 Global Invasive Fungal Disease (IFD) Drugs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Invasive Fungal Disease (IFD) Drugs Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Invasive Fungal Disease (IFD) Drugs Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Oral Medicine Market Size by Players
3.3.2 Injectable Medicine Market Size by Players
3.4 Global Invasive Fungal Disease (IFD) Drugs Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Invasive Fungal Disease (IFD) Drugs Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Invasive Fungal Disease (IFD) Drugs Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Invasive Fungal Disease (IFD) Drugs Market Size by Type (2020-2031)
6.4 North America Invasive Fungal Disease (IFD) Drugs Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Type (2020-2031)
7.4 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Type (2020-2031)
8.4 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Invasive Fungal Disease (IFD) Drugs Market Size by Type (2020-2031)
9.4 Central and South America Invasive Fungal Disease (IFD) Drugs Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Invasive Fungal Disease (IFD) Drugs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Invasive Fungal Disease (IFD) Drugs Market Size by Type (2020-2031)
10.4 Middle East and Africa Invasive Fungal Disease (IFD) Drugs Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.1.4 Pfizer Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer Invasive Fungal Disease (IFD) Drugs Revenue by Product in 2024
11.1.6 Pfizer Invasive Fungal Disease (IFD) Drugs Revenue by Application in 2024
11.1.7 Pfizer Invasive Fungal Disease (IFD) Drugs Revenue by Geographic Area in 2024
11.1.8 Pfizer Invasive Fungal Disease (IFD) Drugs SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview
11.2.3 Merck Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.2.4 Merck Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.2.5 Merck Invasive Fungal Disease (IFD) Drugs Revenue by Product in 2024
11.2.6 Merck Invasive Fungal Disease (IFD) Drugs Revenue by Application in 2024
11.2.7 Merck Invasive Fungal Disease (IFD) Drugs Revenue by Geographic Area in 2024
11.2.8 Merck Invasive Fungal Disease (IFD) Drugs SWOT Analysis
11.2.9 Merck Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Corporation Information
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.3.4 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.3.5 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Revenue by Product in 2024
11.3.6 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Revenue by Application in 2024
11.3.7 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Revenue by Geographic Area in 2024
11.3.8 Gilead Sciences Invasive Fungal Disease (IFD) Drugs SWOT Analysis
11.3.9 Gilead Sciences Recent Developments
11.4 Xellia
11.4.1 Xellia Corporation Information
11.4.2 Xellia Business Overview
11.4.3 Xellia Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.4.4 Xellia Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.4.5 Xellia Invasive Fungal Disease (IFD) Drugs Revenue by Product in 2024
11.4.6 Xellia Invasive Fungal Disease (IFD) Drugs Revenue by Application in 2024
11.4.7 Xellia Invasive Fungal Disease (IFD) Drugs Revenue by Geographic Area in 2024
11.4.8 Xellia Invasive Fungal Disease (IFD) Drugs SWOT Analysis
11.4.9 Xellia Recent Developments
11.5 Lupin Limited
11.5.1 Lupin Limited Corporation Information
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.5.4 Lupin Limited Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.5.5 Lupin Limited Invasive Fungal Disease (IFD) Drugs Revenue by Product in 2024
11.5.6 Lupin Limited Invasive Fungal Disease (IFD) Drugs Revenue by Application in 2024
11.5.7 Lupin Limited Invasive Fungal Disease (IFD) Drugs Revenue by Geographic Area in 2024
11.5.8 Lupin Limited Invasive Fungal Disease (IFD) Drugs SWOT Analysis
11.5.9 Lupin Limited Recent Developments
11.6 Abbott
11.6.1 Abbott Corporation Information
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.6.4 Abbott Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.6.5 Abbott Recent Developments
11.7 Creogenic Pharma
11.7.1 Creogenic Pharma Corporation Information
11.7.2 Creogenic Pharma Business Overview
11.7.3 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.7.4 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.7.5 Creogenic Pharma Recent Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Business Overview
11.8.3 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.8.4 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.8.5 Taj Pharmaceuticals Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Corporation Information
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.9.4 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.9.5 Astellas Pharma Recent Developments
11.10 Jiangsu Aosaikang Pharmaceutical
11.10.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
11.10.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.10.3 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Product Features and Attributes
11.10.4 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Invasive Fungal Disease (IFD) DrugsIndustry Chain Analysis
12.1 Invasive Fungal Disease (IFD) Drugs Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Invasive Fungal Disease (IFD) Drugs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Invasive Fungal Disease (IFD) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Pfizer Inc
Merck
Gilead Sciences
Xellia
Lupin Ltd
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical
List of Tables
 Table 1. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Invasive Fungal Disease (IFD) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Invasive Fungal Disease (IFD) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Invasive Fungal Disease (IFD) Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Invasive Fungal Disease (IFD) Drugs by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Disease (IFD) Drugs as of 2024)
 Table 11. Global Invasive Fungal Disease (IFD) Drugs Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Invasive Fungal Disease (IFD) Drugs Companies Headquarters
 Table 13. Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Invasive Fungal Disease (IFD) Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Invasive Fungal Disease (IFD) Drugs Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Invasive Fungal Disease (IFD) Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Invasive Fungal Disease (IFD) Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Invasive Fungal Disease (IFD) Drugs High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Invasive Fungal Disease (IFD) Drugs Growth Accelerators and Market Barriers
 Table 25. North America Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Invasive Fungal Disease (IFD) Drugs Growth Accelerators and Market Barriers
 Table 27. Europe Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Invasive Fungal Disease (IFD) Drugs Investment Opportunities and Key Challenges
 Table 31. Central and South America Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Invasive Fungal Disease (IFD) Drugs Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Invasive Fungal Disease (IFD) Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Pfizer Corporation Information
 Table 35. Pfizer Description and Major Businesses
 Table 36. Pfizer Product Features and Attributes
 Table 37. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Pfizer Revenue Proportion by Product in 2024
 Table 39. Pfizer Revenue Proportion by Application in 2024
 Table 40. Pfizer Revenue Proportion by Geographic Area in 2024
 Table 41. Pfizer Invasive Fungal Disease (IFD) Drugs SWOT Analysis
 Table 42. Pfizer Recent Developments
 Table 43. Merck Corporation Information
 Table 44. Merck Description and Major Businesses
 Table 45. Merck Product Features and Attributes
 Table 46. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Merck Revenue Proportion by Product in 2024
 Table 48. Merck Revenue Proportion by Application in 2024
 Table 49. Merck Revenue Proportion by Geographic Area in 2024
 Table 50. Merck Invasive Fungal Disease (IFD) Drugs SWOT Analysis
 Table 51. Merck Recent Developments
 Table 52. Gilead Sciences Corporation Information
 Table 53. Gilead Sciences Description and Major Businesses
 Table 54. Gilead Sciences Product Features and Attributes
 Table 55. Gilead Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Gilead Sciences Revenue Proportion by Product in 2024
 Table 57. Gilead Sciences Revenue Proportion by Application in 2024
 Table 58. Gilead Sciences Revenue Proportion by Geographic Area in 2024
 Table 59. Gilead Sciences Invasive Fungal Disease (IFD) Drugs SWOT Analysis
 Table 60. Gilead Sciences Recent Developments
 Table 61. Xellia Corporation Information
 Table 62. Xellia Description and Major Businesses
 Table 63. Xellia Product Features and Attributes
 Table 64. Xellia Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Xellia Revenue Proportion by Product in 2024
 Table 66. Xellia Revenue Proportion by Application in 2024
 Table 67. Xellia Revenue Proportion by Geographic Area in 2024
 Table 68. Xellia Invasive Fungal Disease (IFD) Drugs SWOT Analysis
 Table 69. Xellia Recent Developments
 Table 70. Lupin Limited Corporation Information
 Table 71. Lupin Limited Description and Major Businesses
 Table 72. Lupin Limited Product Features and Attributes
 Table 73. Lupin Limited Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Lupin Limited Revenue Proportion by Product in 2024
 Table 75. Lupin Limited Revenue Proportion by Application in 2024
 Table 76. Lupin Limited Revenue Proportion by Geographic Area in 2024
 Table 77. Lupin Limited Invasive Fungal Disease (IFD) Drugs SWOT Analysis
 Table 78. Lupin Limited Recent Developments
 Table 79. Abbott Corporation Information
 Table 80. Abbott Description and Major Businesses
 Table 81. Abbott Product Features and Attributes
 Table 82. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Abbott Recent Developments
 Table 84. Creogenic Pharma Corporation Information
 Table 85. Creogenic Pharma Description and Major Businesses
 Table 86. Creogenic Pharma Product Features and Attributes
 Table 87. Creogenic Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Creogenic Pharma Recent Developments
 Table 89. Taj Pharmaceuticals Corporation Information
 Table 90. Taj Pharmaceuticals Description and Major Businesses
 Table 91. Taj Pharmaceuticals Product Features and Attributes
 Table 92. Taj Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Taj Pharmaceuticals Recent Developments
 Table 94. Astellas Pharma Corporation Information
 Table 95. Astellas Pharma Description and Major Businesses
 Table 96. Astellas Pharma Product Features and Attributes
 Table 97. Astellas Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma Recent Developments
 Table 99. Jiangsu Aosaikang Pharmaceutical Corporation Information
 Table 100. Jiangsu Aosaikang Pharmaceutical Description and Major Businesses
 Table 101. Jiangsu Aosaikang Pharmaceutical Product Features and Attributes
 Table 102. Jiangsu Aosaikang Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Jiangsu Aosaikang Pharmaceutical Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Invasive Fungal Disease (IFD) Drugs Product Picture
 Figure 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Oral Medicine Product Picture
 Figure 4. Injectable Medicine Product Picture
 Figure 5. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Drugstore
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Invasive Fungal Disease (IFD) Drugs Report Years Considered
 Figure 11. Global Invasive Fungal Disease (IFD) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Invasive Fungal Disease (IFD) Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Region (2020-2031)
 Figure 15. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Oral Medicine Revenue Market Share by Player in 2024
 Figure 18. Injectable Medicine Revenue Market Share by Player in 2024
 Figure 19. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2020-2031)
 Figure 20. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2020-2031)
 Figure 21. North America Invasive Fungal Disease (IFD) Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) in 2024
 Figure 23. North America Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Invasive Fungal Disease (IFD) Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) in 2024
 Figure 30. Europe Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 33. France Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 45. India Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Invasive Fungal Disease (IFD) Drugs Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Invasive Fungal Disease (IFD) Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) in 2024
 Figure 53. Central and South America Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Invasive Fungal Disease (IFD) Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) in 2024
 Figure 59. South America Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Invasive Fungal Disease (IFD) Drugs Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Invasive Fungal Disease (IFD) Drugs Revenue (2020-2025) & (US$ Million)
 Figure 65. Invasive Fungal Disease (IFD) Drugs Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Invasive Fungal Disease IFD Infection Diagnostic Reagent Market Research Report 2025
Invasive Fungal Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti invasive Fungal Infection IFI Drug Market Research Report 2024
Global Fungal 1 3 β D Glucan Detection Kit Market Research Report 2024
Global Fungal Infection Diagnosis Market Insights Forecast to 2030
Global Fungal Infection Rapid Diagnosis Kit Market Research Report 2024
Global Voriconazole Vfend Market Research Report 2024
Global Fungal Infection Diagnostic Kit Market Research Report 2024
Global Fluconazole Preparation Market Research Report 2024
Systemic Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunological Testing for Invasive Fungal Infections Market Research Report 2024
Global Antifungal Drugs for Skin Market Research Report 2024
Global Mucormycosis Treatment Drugs Market Research Report 2025
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azole Antifungals Market Research Report 2024
Global Fenticonazole Market Research Report 2024
Global Anti fungal Drugs Market Insights Forecast to 2030
Global Isavuconazole Sulfate for Injection Market Research Report 2024
Global Posaconazole Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions